Region-dependent absorption of faropenem shared with foscarnet, a phosphate transporter substrate, in the rat small intestine

International Journal of Antimicrobial Agents

Volumn 32, Issue 3, 2008, Pages 267-271

  Saitoh, Hiroshi ^a   Sawazaki, Rinako ^a   Oda, Masako ^a   Kobayashi, Michiya ^a  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

Faropenem; Foscarnet; Intestinal absorption; Intestinal loop; Penem antibiotic; Phosphate transporter

Indexed keywords

CARNOSINE; CEFOTAXIME; FOSCARNET; FROPENEM; GLYCYLGLYCINE; MEROPENEM; PHOSPHATE TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DUODENUM; ENZYMATIC DEGRADATION; ILEUM; INTESTINE MUCOSA; JEJUNUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMALL INTESTINE; SMALL INTESTINE ABSORPTION;

ANIMALS; ANTIVIRAL AGENTS; BETA-LACTAMS; FOSCARNET; INTESTINAL ABSORPTION; INTESTINE, SMALL; MALE; PHOSPHATE TRANSPORT PROTEINS; RATS; RATS, WISTAR;

EID: 49749131559     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.04.006     Document Type: Article

References (15)

1. Tenover F.C. Mechanisms of antimicrobial resistance in bacteria. Am J Med 119 Suppl. 1 (2006) S3-S10
2. Dalhoff A., Janjic N., and Echols R. Redefining penems. Biochem Pharmacol 71 (2006) 1085-1095
3. Schurek K.N., Wieber R., Karlowsky J.A., Rubinstein E., Hoban D.J., and Zhanel G.G. Faropenem: review of a new oral penem. Expert Rev Anti Infect Ther 5 (2007) 185-198
4. Tsuji A. Impact of transporter-mediated drug absorption, distribution, elimination and drug interactions in antimicrobial chemotherapy. J Infect Chemother 12 (2006) 241-250
5. Bronson J.J., and Barrett J.F. Quinolone, everninomycin, carbapenem, lipopeptide and cephem antibacterials in clinical development. Curr Med Chem 8 (2001) 1775-1793
6. Saitoh H., Kobayashi M.-K., Oda M., Nakasato K., Kobayashi M.-C., and Tadano K. Characterization of intestinal absorption and enterohepatic circulation of mycophenolic acid and its 7-O-glucuronide in rats. Drug Metab Pharmacokinet 21 (2006) 406-413
7. Tsuji A. Biopharmaceutical studies on molecular mechanism of membrane transport. Yakugaku Zasshi 122 (2002) 1037-1058
8. Tamai I., Sai Y., Ono A., Kido Y., Yabuuchi H., Takanaga H., et al. Immunohistochemical and functional characterization of pH-dependent intestinal absorption of weak organic acids by the monocarboxylic acid transporter MCT1. J Pharm Pharmacol 51 (1999) 1113-1121
9. Uchino H., Tamai I., Yabuuchi H., China K., Miyamoto K., Takeda E., et al. Faropenem transport across the renal epithelial luminal membrane via inorganic phosphate transporter Npt1. Antimicrob Agents Chemother 44 (2000) 574-577
10. Yabuuchi H., Tamai I., Morita K., Kouda T., Miyamoto K., Takeda E., et al. Hepatic sinusoidal membrane transport of anionic drugs mediated by anion transporter NPT1. J Pharmacol Exp Ther 286 (1998) 1391-1396
11. Murder H., Forster I., and Bibber J. The sodium phosphate cotransporter family SLC34. Pflugers Arch 447 (2004) 763-767
12. i cotransporter in mouse small intestine. Am J Physiol Gastrointest Liver Physiol 288 (2005) G496-G500
13. Swaan P.W., and Tukker J.J. Carrier-mediated transport mechanism of foscarnet (trisodium phosphonoformate hexahydrate) in rat intestinal tissue. J Pharmacol Exp Ther 272 (1995) 242-247
14. + and pH dependent transport of foscarnet via the phosphate carrier system across intestinal brush-border membrane. Biochem Pharmacol 38 (1989) 1019-1022
15. Uchino H., Tamai I., Yamashita K., Minemoto Y., Sai Y., Yabuuchi H., et al. p-Aminohippuric acid transport at renal apical membrane mediated by human inorganic phosphate transporter NPT1. Biochem Biophys Res Commun 270 (2000) 254-259